scispace - formally typeset
D

Debra Hoppensteadt

Researcher at Loyola University Chicago

Publications -  466
Citations -  7440

Debra Hoppensteadt is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Heparin & Anticoagulant. The author has an hindex of 41, co-authored 433 publications receiving 6706 citations. Previous affiliations of Debra Hoppensteadt include Aalborg Hospital & Loyola University Medical Center.

Papers
More filters
Journal ArticleDOI

Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims

TL;DR: An important role for IL-1β, IL-6, and TNF-α in the pathophysiology of suicidal behavior is suggested and that proinflammatory cytokines may be an appropriate target for developing therapeutic agents are suggested.
Journal ArticleDOI

Treatment of Severe Veno-Occlusive Disease With Defibrotide: Compassionate Use Results in Response Without Significant Toxicity in a High-Risk Population

TL;DR: Nineteen patients who developed severe VOD after SCT were treated with DF on a compassionate-use basis and the observed response rate, survival to day +100, and absence of significant DF treatment-associated toxicity are compelling and warrant further evaluation.
Journal ArticleDOI

Pro-inflammatory biomakers in depression: Treatment with venlafaxine

TL;DR: A concave quadratic equation described the associations between plasma venlafaxine concentrations and IL1β, T NFα, TNFα, and MCP-1, suggesting that these biomarkers may have become selectively lowered in the serotonergic dose range of venl Lafaxine.
Journal ArticleDOI

An update on heparins at the beginning of the new millennium.

TL;DR: The introduction of low-molecular-weight heparins (LMWHs) represents a major advance in improving the use of heparin and the development of the oral formulation of he parin and LMWHs provides an important area that may impact on the use.
Journal ArticleDOI

Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

TL;DR: Both gel electrophoresis and high-pressure liquid chromatography mapping techniques showed a greater structural diversity between low molecular weight heparins than had previously been observed between similarly analyzed commercial heparin preparations.